Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
This is an On-demand recording from December 2021
IVD manufacturers are expected to face many challenges during the transition to compliance with the EU’s new requirements for IVDS, the IVDR.
This webcast will discuss the potential impact of the IVDR on new and existing (legacy) devices and important considerations for determining an appropriate regulatory pathway and application strategy.
May 2022 is closer than we think and IVD manufacturers in the EU market have a lot to do in preparation for the 26 May 2022 IVDR date of implementation, as most will no longer be able to rely on market access with the current IVDD certificate. The new reality for manufacturers includes facing additional scrutiny by EU Notified Bodies and Competent Authorities, installing a Person Responsible for Regulatory Compliance (PRRC) and carrying out additional testing and performance investigations.This webcast will cover these major themes of the IVDR with actionable information on tackling the most important requirements. Specific topics to be covered include:
At the conclusion of this program, attendees will understand:
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
Regulatory affairs professionals (specialists, managers, and directors)
Alex Laan currently holds the position of principal consultant at NAMSA. Previously, he worked as principal certification manager at DEKRA Certification BV, a notified body for in vitro diagnostic (IVD) medical devices, located in the Netherlands. Laan also has worked at KEMA Quality, where he was lead assessor for medical devices and IVD devices, and device specialist reviewer in IVDs and medical devices, including drug-device combinations. He is an active member of the IVD working group within EU notified bodies and TEAM-NB, and acts as direct contact for EU competent authorities.
Laan’s educational background is in bioprocess technology and biochemistry engineering. He has worked as a product specialist in immunohematological and plasma products with Sanquin Blood Transfusion Services, Amsterdam, and as a quality assurance and regulatory affairs manager for IVD medical devices at Meddens Diagnostics/IBL, Hamburg.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation.
All cancellation requests must be submitted in writing to firstname.lastname@example.org. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email email@example.com with the event title, name of the original registrant and the contact information for the new attendee.
RAPS will send an electronic letter or a certificate of attendance at the following the workshop.